Skip Navigation


JAC Advance Access originally published online on October 21, 2005
Journal of Antimicrobial Chemotherapy 2006 57(1):150-151; doi:10.1093/jac/dki394
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/1/150    most recent
dki394v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Gascun, C.
Right arrow Articles by Smyth, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Gascun, C.
Right arrow Articles by Smyth, E. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus

C. De Gascun*, L. Rajan, E. O'Neill and E. G. Smyth

Department of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland

* Corresponding author. E-mail: cfbdeg@hotmail.com

Keywords: S. aureus , cytokines , exotoxins , antimicrobial activity

The first 10% of the full text of this article appears below.

Sir,

We read with interest the correspondence from De Bels et al.1 Given the tissue penetration data available on the two agents in question, however, it is not surprising that linezolid proved to be successful where vancomycin had failed in a case of septic arthritis.2 We present a similar case, but of methicillin-susceptible Staphylococcus aureus (MSSA)-induced sepsis, which only responded to antimicrobial therapy after linezolid had been added to a regimen of flucloxacillin, fusidic . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
C. Thallinger, C. Buerger, N. Plock, S. Kljucar, S. Wuenscher, R. Sauermann, C. Kloft, and C. Joukhadar
Effect of severity of sepsis on tissue concentrations of linezolid
J. Antimicrob. Chemother., January 1, 2008; 61(1): 173 - 176.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
V. O. De Beeck, N. Dhif, J. Philipp, and D. De Bels
Comment on: Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus
J. Antimicrob. Chemother., March 1, 2006; 57(3): 577 - 577.
[Full Text] [PDF]